Augusta’s Rob Fahrenheim at the Pharma & Biotech Patent Litigation Forum
February 27th 2019
Rob is an Investment Manager in the Commercial Litigation team, with a particular focus on funding Intellectual Property litigation.
Rob’s role involves sourcing disputes, reviewing cases and undertaking commercial and financial structuring decisions to ensure the successful funding of matters. He is known for taking an open-minded, flexible and innovative approach to funding claims. His expertise in his area enables Augusta to fund a broad range of Intellectual Property disputes, including standalone and non-damages claims.
Prior to joining Augusta, Rob was a member of the IP department at Bird & Bird. His practice focussed on intellectual property litigation, predominantly patent and trade mark disputes in the life sciences and media, entertainment and sport sectors. Whilst at Bird & Bird Rob acted for multinationals, SMEs and private individuals in a variety of ground-breaking disputes. He also has experience of coordinating litigation on behalf of groups of claimants, as well as managing pan-EU litigation strategies. Rob’s experience in the area allows him to devise creative and practical funding solutions for claimants and law firms alike.
Rob holds an MSc in Intellectual Property Law from St Mary’s University London, in addition to a Pharmacology degree and LLB in Law from Nottingham Law School.